Firms
Theme

QUSETF

State Street SPDR MSCI USA StrategicFactors ETF · NYSE ARCA

News

2 latest

Zacks Investment Research

Should State Street SPDR MSCI USA StrategicFactors ETF (QUS) Be on Your Investing Radar?

The State Street SPDR MSCI USA StrategicFactors ETF (QUS) is reviewed as a reasonable large-cap blend option with $1.60 billion in assets and a low 0.15% expense ratio. The ETF has gained 13.66% year-to-date and 15.84% over the past year, with a medium-risk profile. However, it receives a Zacks ETF Rank of 3 (Hold), and competitors like Vanguard 500 Index Fund and iShares Core S&P 500 ETF offer lower expense ratios.

Zacks Investment Research

Is State Street SPDR MSCI USA StrategicFactors ETF (QUS) a Strong ETF Right Now?

The State Street SPDR MSCI USA StrategicFactors ETF (QUS) is a smart beta ETF with $1.59 billion in assets, offering broad exposure to large-cap U.S. equities. With a low 0.15% expense ratio, year-to-date gains of 13.4%, and a diversified portfolio of 516 holdings, it presents a reasonable option for investors seeking to outperform the large-cap blend segment. However, traditional market cap-weighted alternatives like VOO and IVV offer lower expense ratios and may be more suitable for cost-conscious investors.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $QUS · 0 threads

Sign in to post on $QUS

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev